Taysha Gene Therapies Net Debt Growth & History (TSHA)

Taysha Gene Therapies's net debt was −$249.6M for fiscal 2025.

View full Taysha Gene Therapies company overview

Taysha Gene Therapies annual net debt history

Taysha Gene Therapies annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-12-31−$249.6M−$174.1M
20242024-12-31−$75.5M$6.6M
20232023-12-31−$82.1M−$55.2M
20222022-12-31−$26.8M$85.1M
20212021-12-31−$111.9M

Taysha Gene Therapies net debt trends

Between the periods ended 2021-12-31 and 2025-12-31, Taysha Gene Therapies's net debt decreased from −$111.9M to −$249.6M, a change of −$137.7M. The latest reported quarter, Q2 2026, shows −$398.7M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Taysha Gene Therapies source filings ↗

Community posts

It’s quiet here.

No posts about TSHA yet. Start the conversation.

Write the first post